Wai Kit Woo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Wai Kit Woo has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
Julian M. Handley
Department of Dermatology, Ulster Hospital, Belfast, United Kingdom
3 shared publicationsZaid F. Jasim
Department of Dermatology, Ulster Hospital, Belfast, United Kingdom
2 shared publicationsJ. M. Handley
Department of Dermatology, Ulster Hospital, Belfast BT16 0RH, UK
1 shared publicationJ.C. Mcmillan
Department of Dermatology, Belfast City Hospital, Belfast, U.K. *Regional Immunology Laboratory, Departments of †Gastroenterology and ‡Pathology, Royal Hospitals, Belfast BT12 6BA, U.K.
1 shared publicationJ.M. Sloan
Department of Dermatology, Belfast City Hospital, Belfast, U.K. *Regional Immunology Laboratory, Departments of †Gastroenterology and ‡Pathology, Royal Hospitals, Belfast BT12 6BA, U.K.
1 shared publicationJulian M. Md Handley
Department of Dermatology, Ulster Hospital, Belfast, United Kingdom
1 shared publication
Latest Publications
- 1 October 2004
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 151 (4) , 891-894
Coeliac disease-associated antibodies correlate with psoriasis activity
Antigliadin antibodies (AGA) have been reported in patients with psoriasis. To determine if AGA and other coeliac disease (CD)-associated antibodies correlate with clinical features and activity in patients with psoriasis. Patients with psoriasis (n = 130) were investigated for serum IgG and IgA AGA, IgA antitransglutaminase antibody and IgA antiendomysial antibody. Disease characteristics and associated bowel and joint symptoms were determined. All patients were invited to undertake endoscopy with duodenal biopsy. A significantly higher proportion of patients with elevated CD-associated antibody levels was currently on or had previously required systemic immunosuppressants (methotrexate, ciclosporin or etretinate; P = 0.04) or psoralen plus ultraviolet A phototherapy (P = 0.03). One case of CD was diagnosed. The presence of CD-associated antibodies in psoriasis patients correlates with greater disease activity.
- 1 October 2004
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 151 (4) , 891-894
Coeliac disease-associated antibodies correlate with psoriasis activity
Antigliadin antibodies (AGA) have been reported in patients with psoriasis. To determine if AGA and other coeliac disease (CD)-associated antibodies correlate with clinical features and activity in patients with psoriasis. Patients with psoriasis (n = 130) were investigated for serum IgG and IgA AGA, IgA antitransglutaminase antibody and IgA antiendomysial antibody. Disease characteristics and associated bowel and joint symptoms were determined. All patients were invited to undertake endoscopy with duodenal biopsy. A significantly higher proportion of patients with elevated CD-associated antibody levels was currently on or had previously required systemic immunosuppressants (methotrexate, ciclosporin or etretinate; P = 0.04) or psoralen plus ultraviolet A phototherapy (P = 0.03). One case of CD was diagnosed. The presence of CD-associated antibodies in psoriasis patients correlates with greater disease activity.
- 1 February 2004
- Published by Wolters Kluwer Health in Dermatologic Surgery
- Vol. 30 (2) , 158-162
Evaluating the Efficacy of Treatment of Resistant Port-Wine Stains With Variable-Pulse 595-nm Pulsed Dye and 532-nm Nd:YAG Lasers
Some port wine stains (PWSs), despite multiple treatments with the 585-nm 0.45-ms pulsed dye laser (PDL), fail to improve substantially. To determine the efficacy and tolerability of variable pulse width 595-nm PDL and 532-nm Nd:YAG laser in the treatment of resistant PWS. Twenty-two patients whose PWS failed to achieve more than 75% lightening after more than 15 treatments with the 585-nm 0.45-ms PDL were recruited. A homogenous patch of PWS was divided into five areas. Area 1 (control area) was treated with 585-nm, 0.45-ms PDL (fluence 7.5 J/cm2). Areas 2 and 3 were treated with 595-nm PDL at fluence 15 J/cm2 (with cryogen spray cooling) and pulse durations of 1.5 and 10 ms, respectively. Areas 4 and 5 were treated with a 532-nm Nd:YAG laser at 2 ms, 7 J/cm2 and 10 ms, 16 J/cm2, respectively (with a contact cooling tip). The response was assessed by photographic evaluation. Three patients had further lightening in area 2, and two patients had further lightening in area 3. Each of three patients had further lightening in areas 4 and 5, respectively. One patient had further lightening in the control area. In individual patients, it may be effective to treat resistant PWS with the variable-pulse width 595-nm PDL and the 532-nm Nd:YAG laser.
- 1 February 2004
- Published by Wolters Kluwer Health in Dermatologic Surgery
- Vol. 30 (2) , 158-162
Evaluating the Efficacy of Treatment of Resistant Port-Wine Stains With Variable-Pulse 595-nm Pulsed Dye and 532-nm Nd:YAG Lasers
Some port wine stains (PWSs), despite multiple treatments with the 585-nm 0.45-ms pulsed dye laser (PDL), fail to improve substantially. To determine the efficacy and tolerability of variable pulse width 595-nm PDL and 532-nm Nd:YAG laser in the treatment of resistant PWS. Twenty-two patients whose PWS failed to achieve more than 75% lightening after more than 15 treatments with the 585-nm 0.45-ms PDL were recruited. A homogenous patch of PWS was divided into five areas. Area 1 (control area) was treated with 585-nm, 0.45-ms PDL (fluence 7.5 J/cm2). Areas 2 and 3 were treated with 595-nm PDL at fluence 15 J/cm2 (with cryogen spray cooling) and pulse durations of 1.5 and 10 ms, respectively. Areas 4 and 5 were treated with a 532-nm Nd:YAG laser at 2 ms, 7 J/cm2 and 10 ms, 16 J/cm2, respectively (with a contact cooling tip). The response was assessed by photographic evaluation. Three patients had further lightening in area 2, and two patients had further lightening in area 3. Each of three patients had further lightening in areas 4 and 5, respectively. One patient had further lightening in the control area. In individual patients, it may be effective to treat resistant PWS with the variable-pulse width 595-nm PDL and the 532-nm Nd:YAG laser.
- 1 December 2003
- Published by Wolters Kluwer Health in Dermatologic Surgery
- Vol. 29 (12) , 1192-1195
A Pilot Study on the Treatment of Facial Rhytids Using Nonablative 585-nm Pulsed Dye and 532-nm Nd:YAG Lasers
BACKGROUND There have been reports of successfully using the pulsed dye laser and long-pulse Nd:YAG laser to improve skin wrinkles. OBJECTIVE To evaluate the efficacy of these lasers in the treatment of moderate to severe wrinkles. METHODS Seven subjects had one side of their periorbital wrinkles treated with pulsed dye laser (585 nm, 0.45 ms, 2.5 J/cm2, single-pass 10% overlap, three treatments at 6 weeks apart). The second part of the study involved using the long-pulse Nd:YAG laser (532 nm, 2 ms, 7.0 J/cm2 with cooling, three laser passes, three treatments at 6 weeks apart) to treat the contralateral wrinkles in five subjects. Pretreatment and posttreatment photographs were taken, and blinded assessors were asked to choose the better of the two unlabeled photographs. RESULTS Assessors found that two of the seven subjects had a better posttreatment photograph in the pulsed dye laser-treated group. Three of five subjects had a better posttreatment photograph in the long-pulse Nd:YAG laser-treated group. None of the subjects reported any subjective improvements. CONCLUSION Neither the pulsed dye laser nor the long-pulse Nd:YAG laser at the previously mentioned parameters produced any improvement in moderate to severe facial wrinkles.
- 1 December 2003
- Published by Wolters Kluwer Health in Dermatologic Surgery
- Vol. 29 (12) , 1192-1195
A Pilot Study on the Treatment of Facial Rhytids Using Nonablative 585-nm Pulsed Dye and 532-nm Nd:YAG Lasers
BACKGROUND There have been reports of successfully using the pulsed dye laser and long-pulse Nd:YAG laser to improve skin wrinkles. OBJECTIVE To evaluate the efficacy of these lasers in the treatment of moderate to severe wrinkles. METHODS Seven subjects had one side of their periorbital wrinkles treated with pulsed dye laser (585 nm, 0.45 ms, 2.5 J/cm2, single-pass 10% overlap, three treatments at 6 weeks apart). The second part of the study involved using the long-pulse Nd:YAG laser (532 nm, 2 ms, 7.0 J/cm2 with cooling, three laser passes, three treatments at 6 weeks apart) to treat the contralateral wrinkles in five subjects. Pretreatment and posttreatment photographs were taken, and blinded assessors were asked to choose the better of the two unlabeled photographs. RESULTS Assessors found that two of the seven subjects had a better posttreatment photograph in the pulsed dye laser-treated group. Three of five subjects had a better posttreatment photograph in the long-pulse Nd:YAG laser-treated group. None of the subjects reported any subjective improvements. CONCLUSION Neither the pulsed dye laser nor the long-pulse Nd:YAG laser at the previously mentioned parameters produced any improvement in moderate to severe facial wrinkles.
- 1 December 2003
- Published by Wolters Kluwer Health in Dermatologic Surgery
- Vol. 29 (12) , 1176-1180
532-nm Nd:YAG and 595-nm Pulsed Dye Laser Treatment of Leg Telangiectasia Using Ultralong Pulse Duration
Telangiectatic leg veins have been treated using lasers with variable success. We aimed to examine the efficacy and tolerability of a 595-nm pulsed dye laser (PDL) and a 532-nm Nd:YAG laser using ultralong pulse duration to improve leg telangiectasias with a single treatment. Ten subjects with leg telangiectasias up to 1.0 mm in diameter participated in the study. The telangiectatic patch was divided into two approximately equal adjacent areas. The first area was treated with a 532-nm Nd:YAG laser at a fluence of 20 J/cm2 and a pulse duration of 50 ms using a contact cooling device. The second area was treated with a 595-nm PDL at a fluence of 25 J/cm2 and a pulse duration of 40 ms using cryogen spray precooling. Each area was treated once only. Photographic evaluation was used for an assessment of response. Two of 10 subjects had less than 25%, 3 had 25% to 50%, 2 had 50% to 75%, and 3 had more than 75% improvement after single treatment with a 532-nm Nd:YAG laser. Similarly, 2 of 10 subjects had less than 25%, 2 had 25% to 50%, and 6 had 50% to 75% improvement with the 595-nm PDL. Hyperpigmentation occurred in one subject treated with the 532-nm Nd:YAG laser and two subjects treated with the 595-nm PDL. No blistering, crusting, hypopigmentation, or scarring were observed. Both lasers using ultralong pulse width improved leg telangiectasias after a single treatment with minimal adverse reactions.
- 1 December 2003
- Published by Wolters Kluwer Health in Dermatologic Surgery
- Vol. 29 (12) , 1176-1180
532-nm Nd:YAG and 595-nm Pulsed Dye Laser Treatment of Leg Telangiectasia Using Ultralong Pulse Duration
Telangiectatic leg veins have been treated using lasers with variable success. We aimed to examine the efficacy and tolerability of a 595-nm pulsed dye laser (PDL) and a 532-nm Nd:YAG laser using ultralong pulse duration to improve leg telangiectasias with a single treatment. Ten subjects with leg telangiectasias up to 1.0 mm in diameter participated in the study. The telangiectatic patch was divided into two approximately equal adjacent areas. The first area was treated with a 532-nm Nd:YAG laser at a fluence of 20 J/cm2 and a pulse duration of 50 ms using a contact cooling device. The second area was treated with a 595-nm PDL at a fluence of 25 J/cm2 and a pulse duration of 40 ms using cryogen spray precooling. Each area was treated once only. Photographic evaluation was used for an assessment of response. Two of 10 subjects had less than 25%, 3 had 25% to 50%, 2 had 50% to 75%, and 3 had more than 75% improvement after single treatment with a 532-nm Nd:YAG laser. Similarly, 2 of 10 subjects had less than 25%, 2 had 25% to 50%, and 6 had 50% to 75% improvement with the 595-nm PDL. Hyperpigmentation occurred in one subject treated with the 532-nm Nd:YAG laser and two subjects treated with the 595-nm PDL. No blistering, crusting, hypopigmentation, or scarring were observed. Both lasers using ultralong pulse width improved leg telangiectasias after a single treatment with minimal adverse reactions.
- 1 December 2003
- Published by Wolters Kluwer Health in Dermatologic Surgery
- Vol. 29 (12) , 1192-1195
A Pilot Study on the Treatment of Facial Rhytids Using Nonablative 585-nm Pulsed Dye and 532-nm Nd:YAG Lasers
There have been reports of successfully using the pulsed dye laser and long-pulse Nd:YAG laser to improve skin wrinkles. To evaluate the efficacy of these lasers in the treatment of moderate to severe wrinkles. Seven subjects had one side of their periorbital wrinkles treated with pulsed dye laser (585 nm, 0.45 ms, 2.5 J/cm2, single-pass 10% overlap, three treatments at 6 weeks apart). The second part of the study involved using the long-pulse Nd:YAG laser (532 nm, 2 ms, 7.0 J/cm2 with cooling, three laser passes, three treatments at 6 weeks apart) to treat the contralateral wrinkles in five subjects. Pretreatment and posttreatment photographs were taken, and blinded assessors were asked to choose the better of the two unlabeled photographs. Assessors found that two of the seven subjects had a better posttreatment photograph in the pulsed dye laser-treated group. Three of five subjects had a better posttreatment photograph in the long-pulse Nd:YAG laser-treated group. None of the subjects reported any subjective improvements. Neither the pulsed dye laser nor the long-pulse Nd:YAG laser at the previously mentioned parameters produced any improvement in moderate to severe facial wrinkles.
- 1 December 2003
- Published by Wolters Kluwer Health in Dermatologic Surgery
- Vol. 29 (12) , 1192-1195
A Pilot Study on the Treatment of Facial Rhytids Using Nonablative 585-nm Pulsed Dye and 532-nm Nd:YAG Lasers
There have been reports of successfully using the pulsed dye laser and long-pulse Nd:YAG laser to improve skin wrinkles. To evaluate the efficacy of these lasers in the treatment of moderate to severe wrinkles. Seven subjects had one side of their periorbital wrinkles treated with pulsed dye laser (585 nm, 0.45 ms, 2.5 J/cm2, single-pass 10% overlap, three treatments at 6 weeks apart). The second part of the study involved using the long-pulse Nd:YAG laser (532 nm, 2 ms, 7.0 J/cm2 with cooling, three laser passes, three treatments at 6 weeks apart) to treat the contralateral wrinkles in five subjects. Pretreatment and posttreatment photographs were taken, and blinded assessors were asked to choose the better of the two unlabeled photographs. Assessors found that two of the seven subjects had a better posttreatment photograph in the pulsed dye laser-treated group. Three of five subjects had a better posttreatment photograph in the long-pulse Nd:YAG laser-treated group. None of the subjects reported any subjective improvements. Neither the pulsed dye laser nor the long-pulse Nd:YAG laser at the previously mentioned parameters produced any improvement in moderate to severe facial wrinkles.
- 30 October 2003
- Published by Oxford University Press (OUP) in Clinical and Experimental Dermatology
- Vol. 28 (6) , 672-673
Iatrogenic adrenal gland suppression from use of a potent topical steroid
- 30 October 2003
- Published by Oxford University Press (OUP) in Clinical and Experimental Dermatology
- Vol. 28 (6) , 672-673
Iatrogenic adrenal gland suppression from use of a potent topical steroid
- 29 August 2003
- Published by Oxford University Press (OUP) in Clinical and Experimental Dermatology
- Vol. 28 (5) , 556-557
Does fluence matter in the laser treatment of port-wine stains?
- 29 August 2003
- Published by Oxford University Press (OUP) in Clinical and Experimental Dermatology
- Vol. 28 (5) , 556-557
Does fluence matter in the laser treatment of port-wine stains?
- 1 July 2003
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 149 (1) , 146-150
Combination TL01 ultraviolet B phototherapy and topical calcipotriol for psoriasis: a prospective randomized placebo-controlled clinical trial
Summary Background Previous studies have demonstrated the ultraviolet (UV)‐sparing effect of combining topical calcipotriol with broadband UVB in the treatment of psoriasis. Objectives To determine...
- 1 July 2003
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 149 (1) , 146-150
Combination TL01 ultraviolet B phototherapy and topical calcipotriol for psoriasis: a prospective randomized placebo-controlled clinical trial
Summary Background Previous studies have demonstrated the ultraviolet (UV)‐sparing effect of combining topical calcipotriol with broadband UVB in the treatment of psoriasis. Objectives To determine...